Detalhe da pesquisa
1.
Mutant p53 drives invasion by promoting integrin recycling.
Cell
; 139(7): 1327-41, 2009 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20064378
2.
EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7.
J Cell Sci
; 133(9)2020 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32184261
3.
Interaction of p53 with the CCT complex promotes protein folding and wild-type p53 activity.
Mol Cell
; 50(6): 805-17, 2013 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23747015
4.
Biological relevance of cell-in-cell in cancers.
Biochem Soc Trans
; 47(2): 725-732, 2019 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30850425
5.
The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
Int J Mol Sci
; 20(24)2019 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31817935
6.
Novel targets and interaction partners of mutant p53 Gain-Of-Function.
Biochem Soc Trans
; 44(2): 460-6, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27068955
7.
Mutant p53 regulates Dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype.
J Biol Chem
; 289(1): 122-32, 2014 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24220032
8.
Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer.
Proc Natl Acad Sci U S A
; 109(38): 15312-7, 2012 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22949650
9.
Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasion.
EMBO Rep
; 13(7): 638-44, 2012 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-22653443
10.
The nutritional supplement taurine activates p53-dependent and independent tumor suppressor mechanisms in various cellular models of ovarian cancer.
bioRxiv
; 2023 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36909636
11.
GOF Mutant p53 in Cancers: A Therapeutic Challenge.
Cancers (Basel)
; 14(20)2022 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291874
12.
Nuclear-cytosolic transport of COMMD1 regulates NF-kappaB and HIF-1 activity.
Traffic
; 10(5): 514-27, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19220812
13.
Rab11-FIP1/RCP Functions as a Major Signalling Hub in the Oncogenic Roles of Mutant p53 in Cancer.
Front Oncol
; 11: 804107, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35757381
14.
Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane.
Cell Death Dis
; 12(2): 207, 2021 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33627632
15.
Publisher Correction: Genomic instability in mutant p53 cancer cells upon entotic engulfment.
Nat Commun
; 9(1): 3540, 2018 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30154405
16.
Genomic instability in mutant p53 cancer cells upon entotic engulfment.
Nat Commun
; 9(1): 3070, 2018 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076358
17.
c-Met and Other Cell Surface Molecules: Interaction, Activation and Functional Consequences.
Biomedicines
; 3(1): 46-70, 2015 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28536399
18.
Mutant p53 in cancer: new functions and therapeutic opportunities.
Cancer Cell
; 25(3): 304-17, 2014 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24651012
19.
p53 mutations in cancer.
Nat Cell Biol
; 15(1): 2-8, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23263379
20.
Diacylglycerol kinase α controls RCP-dependent integrin trafficking to promote invasive migration.
J Cell Biol
; 196(2): 277-95, 2012 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22270919